UBC-U of S research offers hope for treatment of age-related blindness

tween anti-inflammatories and macular degeneration.

The researchers emphasize that further study is required to confirm their findings, but if they are corroborated, anti-inflammatories would be the first approach for this intractable disease. Related questions such as optimum dosage and when to begin treatment need to be answered. Also, since NSAIDS can have side effects such as stomach upset, ulcers and stress on kidneys, they are not appropriate for everyone and criteria for high-risk patients that would benefit from their use will need to be defined.

Macular degeneration is the most common cause of severe vision loss in Canada, especially among the elderly, according to the Canadian National Institute for the Blind. It causes one in three cases of reported vision loss. The condition causes light-sensitive cells in the macula, or central portion of the retina, to degenerate. The macula is responsible for perceiving fine visual detail. Early signs of macular degeneration include blurring of vision when performing detailed tasks like reading or sewing.

AMD is the most common form of the disease and causes permanent loss of central vision. There are two forms of AMD wet and dry with more than 85 per cent of cases being the dry form, for which there is no effective treatment.



Page: 1 2

Related medicine news :

1. 1 of 2 pediatric kidney disease research centers in world established
2. Stanford researchers find culprit in aging muscles that heal poorly
3. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
4. Indiana University Imaging Center receives $6M grant for kidney research
5. Penn researchers discover novel pathway for increasing good cholesterol
6. New research discovers independent brain networks control human walking
7. Theory of facial aging gets a facelift from UT Southwestern researchers
8. Sports concussion research using fMRI provides insight for safe return-to-play decisions
9. UIC researchers to develop new drugs to fight bioterrorism
10. New research finds high prevalence of smoking among physicians in China
11. Fat is the new normal, FSU researcher says

Post Your Comments:
TAG: UBC research offers hope for treatment age related blindness

(Date:10/9/2015)... ... October 09, 2015 , ... MMJ ... Innovations with Ed Begley Jr., airing 1st QT 2016 via the Discovery Channel. ... on MMJ Phytotech Limited (MMJ) – a global leader in the field of ...
(Date:10/9/2015)... ... 2015 , ... Ryan Fox, the founder and CEO of ... says the latest figures on the state’s sales of legalized marijuana acknowledge that ... , Last month, according to the website AllGov.com , Colorado's Department ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... Most people ... processed with more vegetables and less meat. While noted T’ai Chi Master and integrative ... “Yin and Yang” relationship between the two cuisines and that they potentially complement one ...
(Date:10/9/2015)... Florida (PRWEB) , ... October 09, 2015 , ... A variety of race options will ... Treatment of Co-occurring Disorders on Sunday, October 18, at Al Lopez Park, 4810 North Himes ... and will include the choice of a 5K run or walk and a one-mile walk, ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... of Kimberly Post, CPA , as Chief Financial Officer. Kimberly will ... compliance and assist with any strategic acquisitions. Kimberly’s experience guiding healthcare services ...
Breaking Medicine News(10 mins):
(Date:10/8/2015)... Calif. , Oct. 8, 2015  Ardelyx, ... company focused on gastrointestinal and cardio-renal diseases, today ... product candidate, tenapanor, will be presented at the ... presented findings will include measures of sustained response ... double blind, placebo-controlled, randomized Phase 2 trial. The ...
(Date:10/8/2015)... 8, 2015  Trovagene, Inc., (NASDAQ:   TROV) ... the presentation of results from a field experience ... Monitoring SM (PCM) platform to accurately identify ... to determine appropriate therapy for patients. Mark ... is delivering the results today in an oral ...
(Date:10/8/2015)... Oct. 8, 2015  Following months of investigation, Ross ... the nation alleging that the anticoagulant Xarelto,s recommended dosage doesn,t ... Philadelphia on behalf of a ... stroke because the drug didn,t work as the manufacturer suggested. ... other suits shortly on behalf of clients from across the ...
Breaking Medicine Technology:
Cached News: